Nuo Therapeutics, Inc. (NUOTQ) - OTCPK - Current
  • Nov. 6, 2014, 11:11 AM
    • Cytomedix (OTCQX:CMXI -1.4%) will report Q3 results on November 13 after the close. The conference call will begin the next day, November 14, at 8:00 am ET.
    | Nov. 6, 2014, 11:11 AM
Company Description
Nuo Therapeutics, Inc. is a biomedical company that pioneers leading-edge biodynamic therapies for wound care. The Company's flagship product, Aurix is a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of a variety of wounds.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States